Recipient risk factors for acute cellular rejection after orthotopic liver transplant ‐ a single‐center, retrospective study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recipient risk factors for acute cellular rejection after orthotopic liver transplant ‐ a single‐center, retrospective study

Published:2020-10-21 Issue:12 Volume:33 Page:1779-1787
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl. Int.

Author:

Choi David¹²^ORCID,Liu Mengyuan¹,Guttikonda Dharani³,Galen Kelly¹²,Guzman Grace⁴,Jeon Hoonbae⁵,Aloman Costica³^ORCID

Affiliation:

1. Division of Gastroenterology and Hepatology University of Illinois at Chicago Chicago IL USA

2. College of Pharmacy University of Illinois at Chicago Chicago IL USA

3. Division of Digestive Diseases and Nutrition Section of Hepatology Rush University Chicago IL USA

4. Department of Pathology University of Illinois at Chicago Chicago IL USA

5. Department of Surgery Division of Transplantation Surgery Tulane University New Orleans LA USA

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Frontiers Media SA

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tri.13756

Reference31 articles.

1. Profiling immunologic risk for acute rejection in liver transplantation: Recipient age is an important risk factor

2. From immunosuppression to tolerance

3. Immunologic Basis of Graft Rejection and Tolerance Following Transplantation of Liver or Other Solid Organs

4. Acute, Chronic, and Humoral Rejection

5. Inflammatory triggers of acute rejection of organ allografts

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Incidence and Risk Factors for Acute Cellular Rejection in a Steroid Sparing Liver Transplant Center;Annals of Pharmacotherapy;2022-08-24

2. Safety of Tacrolimus Monotherapy within 12 Months after Liver Transplantation in the Era of Reduced Tacrolimus and Mycophenolate Mofetil: National Registry Study;Journal of Clinical Medicine;2022-05-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3